Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call
2 Growth Stocks with Explosive Upside and 1 Facing Headwinds
IRTC Q2 Deep Dive: Product Portfolio Expansion and Margin Gains Highlight Quarter
iRhythm (NASDAQ:IRTC) Beats Q2 CY2026 Sales Expectations
Upon closing, combination immediately broadens iRhythm's ambulatory cardiac monitoring portfolio, including in the large and growing mobile cardiac telemetry category, and adds continuous multi-vitals...
SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
SAN FRANCISCO , Aug. 6, 2026 /PRNewswire/ -- Bernstein Litowitz Berger & Grossmann LLP announces that the United States District Court for the Northern District of California has approved the following...